IDO1 and stage 5 chronic kidney disease: In a nephrotoxic serum nephritis mouse model, IDO enzymatic inhibition using 1-MT (-d or -l isomer) exacerbated proteinuria and end-stage renal disease signifying a protective role for IDO (58), although whether this can be accredited to IDO1 or IDO2 was not determined.